Cleveland BioLabs Inc
Biotechnology
Healthcare
CBLI
15.48M shares
NASDAQ US
traded
28 Sep 2021
open
2.42
52 week high
9.55
high
2.58
52 week low
1.97
low
2.34
growth
11.43%
previous Close
2.42
P/E ratio
-62
market cap
49.07M
div yield
0
usd
Mar 2021
qoq
revenue
net incoming
-538.10K
22.54 %
eps
-0.04
82.54 %
eps surprise
0.00 %
net profit margin
-53809800 %
operating incoming
-551.26K
29.05 %
net change in cash
12.41M
1,702.29 %
cash on hand
14.36M
637.73 %
cost of revenue
top top